Indications
Pranlu oral suspension is indicated for asthma and allergic rhinitis symptoms.
Pharmacology
Pranlukast selectively antagonizes leukotriene D4 (LTD4) at the cysteinyl leukotriene receptor in the human airway. It inhibits the actions of LTD4 at the CysLT1 receptor and prevents airway edema, smooth muscle contraction and enhanced secretion of thick, viscous mucus.
Dosage and administration
Child : 3.5 mg/kg bid. Max dose : 10 mg/kg/day (not exceeding 450 mg daily). Adults : Take 2 tablets (225 mg) at a time, twice a day after breakfast and dinner. The dosage may be adjusted according to your age and symptoms. Strictly follow the instructions. Use in Children & Adolescents : There was a substantial benefit of adding pranlukast to usual therapy in asthmatic children.
Interactions
Concurrent use with warfarin and other anticoagulants may cause an increase in prothrombin time.
Contraindications
Pranlukast is contraindicated in acute asthma attacks and hepatic impairment/cirrhosis.
Side effects
Headache, increased incidence of respiratory tract infection, GI disturbances, induced generalized pain, fever, myalgia and arthralgia.
Pregnancy and lactation
Use of pranlukast is not associated with an increased risk of pregnancy loss, gestational diabetes, preeclampsia, low maternal weight, preterm delivery, low apgar scores and reduced measures of birth length in infants. Slightly decreased birth weight in infants born to pranlukast users could be attributed to maternal asthma severity/control.
Precautions and warnings
Should be cautious regarding the patients with renal impairment. Possible elevations in liver enzymes can happen. Withdraw treatment in patients showing signs consistent with Churg-Strauss syndrome.
Storage
Keep below 30°C temperature, protected from light & moisture. Keep all medicines out of reach of children.
Common questions
What is Pranlu used for?
Pranlu oral suspension is indicated for asthma and allergic rhinitis symptoms.
What is the generic name of Pranlu?
Pranlu contains Pranlukast Hydrate, which belongs to the group: Leukotriene receptor antagonists.
Who makes Pranlu?
Pranlu is marketed in Bangladesh by ACME Laboratories Ltd..
How is Pranlu taken?
5 mg/kg bid. Max dose : 10 mg/kg/day (not exceeding 450 mg daily). Always follow your doctor's instructions.
What are the side effects of Pranlu?
Headache, increased incidence of respiratory tract infection, GI disturbances, induced generalized pain, fever, myalgia and arthralgia.
Is Pranlu safe in pregnancy?
Use of pranlukast is not associated with an increased risk of pregnancy loss, gestational diabetes, preeclampsia, low maternal weight, preterm delivery, low apgar scores and reduced measures of birth length in infants. Slightly decreased birth weight in infants born to pranlukast users could be attributed to maternal asthma severity/control. Ask your doctor before using it while pregnant or breastfeeding.
This page is general information and is not medical advice. It does not replace a registered doctor, and it is not a prescription or a recommendation to use any medicine or test. Prices are listed prices and may change. Always follow the advice of your doctor or pharmacist.